title: Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis?
authors.affiliation: Washington University School of Medicine, Department of Pathology and Immunology, St. Louis, Missouri 63110, USA. teitelbs@wustl.edu
authors.forename: Steven L
authors.initials: SL
authors.lastname: Teitelbaum
authors.forename: Margaret P
authors.initials: MP
authors.lastname: Seton
authors.forename: Kenneth G
authors.initials: KG
authors.lastname: Saag
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced* / Q000188:drug therapy*; D058866:Osteoporotic Fractures / Q000209:etiology / Q000517:prevention & control; D012216:Rheumatic Diseases / Q000150:complications / Q000188:drug therapy
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D005938:Glucocorticoids